Diabetes Mellitus: all 11,090 studies

Page 29 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCompletedNCT01095666Phase 3Results posted
• Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIVCompletedNCT01093651Phase 2/3Results posted
• The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes MellitusCompletedNCT01092663Not applicableResults posted
• Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)CompletedNCT01088711Phase 1Results posted
• SEGUDIAB Study: Evaluation of Safety in the Diabetic PatientsCompletedNCT01087541Not applicableResults posted
• Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentCompletedNCT01087502Phase 3Results posted
• Application and Effectiveness Analysis of Internet-based Diabetes Prevention ProgramCompletedNCT01085682Phase 4Results posted
• The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) TrialCompletedNCT01081834Phase 3Results posted
• Comparing Google With A Focused Diabetes Search EngineCompletedNCT01080976Results posted
• Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesCompletedNCT01079234Phase 3Results posted
• Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes MellitusCompletedNCT01079195Results posted
• A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic AgentsCompletedNCT01077323Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01076647Phase 3Results posted
• Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)CompletedNCT01076088Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)CompletedNCT01076075Phase 3Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)CompletedNCT01075282Phase 3Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT01074268Phase 3Results posted
• Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily InjectionsCompletedNCT01073566Phase 2Results posted
• Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 DiabetesCompletedNCT01073020Not applicableResults posted
• To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesCompletedNCT01068860Phase 2Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068678Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068665Phase 3Results posted
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
• Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure ControlCompletedNCT01066039Phase 4Results posted
• Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)CompletedNCT01065766Results posted
• A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01064687Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01064414Phase 3Results posted
• Genetic Testing for Type 2 DiabetesCompletedNCT01060540Not applicableResults posted
• Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesCompletedNCT01060059Results posted
• Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)CompletedNCT01059825Phase 2Results posted
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01059812Phase 3Results posted
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01059799Phase 3Results posted
• Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)CompletedNCT01054300Phase 1Results posted
• Naltrexone and Hypoglycemia in Type 1 DiabetesCompletedNCT01053078Phase 1/2Results posted
• Impact of Diabetes on Left Ventricular RemodelingCompletedNCT01052272Phase 2/3Results posted
• Diabetes Prevention Translation: the Healthy Lifestyle ProjectCompletedNCT01050205Not applicableResults posted
• A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
• Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinCompletedNCT01046110Phase 3Results posted
• Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
• Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCompletedNCT01045447Phase 3Results posted
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseCompletedNCT01042977Phase 3Results posted
• Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?CompletedNCT01040819Phase 4Results posted
• A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)CompletedNCT01034111Phase 3Results posted
• Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)CompletedNCT01033773Not applicableResults posted
• CANVAS - CANagliflozin cardioVascular Assessment StudyCompletedNCT01032629Phase 3Results posted
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionCompletedNCT01031680Phase 3Results posted
• Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedNCT01030952Phase 4Results posted
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"CompletedNCT01030861Phase 2Results posted
• Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01029886Phase 3Results posted
• A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusTerminatedNCT01029795Phase 2Results posted
• Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusCompletedNCT01029704Phase 2Results posted
• Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin RequirementsCompletedNCT01029392Phase 3Results posted
• 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)CompletedNCT01028391Phase 3Results posted
• A Study for Patients With Type 2 DiabetesCompletedNCT01027871Phase 2Results posted
• A Study of LY2599506 in Patients With Type 2 DiabetesTerminatedNCT01024244Phase 2Results posted
• Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesCompletedNCT01023581Phase 3Results posted
• Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
• Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) PatientsCompletedNCT01020123Phase 2Results posted
• Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)CompletedNCT01019486Phase 4Results posted
• Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01009580Phase 3Results posted
• Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold DepressionCompletedNCT01009138Not applicableResults posted
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
• Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminCompletedNCT01006603Phase 4Results posted
• Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 DiabetesCompletedNCT01006590Phase 4Results posted
• Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3Results posted
• Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCompletedNCT01003184Phase 3Results posted
• Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After TransplantationTerminatedNCT01002339Phase 4Results posted
• Gene Therapy for Painful Diabetic NeuropathyCompletedNCT01002235Phase 1/2Results posted
• A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
• Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 DiabetesCompletedNCT00998335Phase 4Results posted
• Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT PatientsCompletedNCT00995930Phase 2Results posted
• University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
• Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 DiabetesCompletedNCT00993824Phase 2/3Results posted
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCompletedNCT00993473Phase 3Results posted
• Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)CompletedNCT00993187Phase 4Results posted
• Study of EndoBarrier Liner for Treatment of Type 2 Diabetes StudyCompletedNCT00986349Not applicableResults posted
• Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and ObesityCompletedNCT00985114Not applicableResults posted
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00982644Phase 3Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00982228Phase 3Results posted
• Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00979628Phase 4Results posted
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00978627Phase 3Results posted
• Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)CompletedNCT00977808Not applicableResults posted
• Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesCompletedNCT00976495Phase 2Results posted
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
• 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineCompletedNCT00975286Phase 3Results posted
• Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)CompletedNCT00972322Phase 1Results posted
• Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesCompletedNCT00972283Phase 3Results posted
• Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT00972244Phase 2Results posted
• Pilot Project of Health Promotion for People With DiabetesCompletedNCT00970294Not applicableResults posted
• CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideCompletedNCT00968812Phase 3Results posted
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeCompletedNCT00968708Phase 3Results posted
• Metformin Compared to Glyburide in Gestational DiabetesCompletedNCT00965991Not applicableResults posted
• Inducing Remission in Type 1 Diabetes With AlefaceptTerminatedNCT00965458Phase 2Results posted
• Study of LX4211 in Subjects With Type 2 Diabetes MellitusCompletedNCT00962065Phase 2Results posted
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesCompletedNCT00960661Phase 3Results posted
• An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesCompletedNCT00960076Phase 3Results posted
• Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusCompletedNCT00957268Phase 1Results posted
• Nurse Telephone Management of Cholesterol in DiabetesCompletedNCT00950963Not applicableResults posted
• Study of Multiple Doses of Saxagliptin (BMS-477118)CompletedNCT00950599Phase 2Results posted
• Canakinumab Study in Individuals With Newly Diagnosed Type 1 DiabetesCompletedNCT00947427Phase 2Results posted

← Diabetes Mellitus overview